C
China NT Pharma Group Company Ltd
HKEX:1011
China NT Pharma Group Company Ltd
HKEX:1011
Price:
0.56
HKD
-16.42%
Market Closed
Market Cap:
HK$531.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China NT Pharma Group Company Ltd
HKEX:1011
|
CN |
|
Tanaka Chemical Corp
TSE:4080
|
JP |
|
One REIT Inc
TSE:3290
|
JP |
|
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
|
CN |
|
S
|
Synel MLL Payway Ltd
TASE:SNEL
|
IL |
|
American Woodmark Corp
NASDAQ:AMWD
|
US |
|
C
|
Chengdu RML Technology Co Ltd
SZSE:301050
|
CN |
|
3
|
3Dm Digital Manufacturing Ltd
TASE:DM3
|
IL |
|
H
|
H World Group Ltd
BMV:HTHTN
|
CN |
|
Unity Software Inc
NYSE:U
|
US |
|
Suzhou MedicalSystem Technology Co Ltd
SSE:603990
|
CN |
|
S
|
Seaboard Corp
AMEX:SEB
|
US |
|
Everest Group Ltd
NYSE:EG
|
BM |
|
H
|
Hangzhou Advance Gearbox Group Co Ltd
SSE:601177
|
CN |
Income Statement
Earnings Waterfall
China NT Pharma Group Company Ltd
China NT Pharma Group Company Ltd
Income Statement
China NT Pharma Group Company Ltd
China NT Pharma Group Company Ltd
Currency: CNY
| Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Interest Expense |
50
|
0
|
52
|
70
|
70
|
70
|
78
|
0
|
27
|
0
|
25
|
0
|
43
|
0
|
80
|
0
|
103
|
0
|
85
|
0
|
89
|
0
|
39
|
0
|
29
|
0
|
32
|
0
|
0
|
|
| Revenue |
2 758
N/A
|
2 299
-17%
|
739
-68%
|
742
+0%
|
754
+2%
|
636
-16%
|
865
+36%
|
837
-3%
|
848
+1%
|
853
+1%
|
360
-58%
|
288
-20%
|
605
+110%
|
602
0%
|
572
-5%
|
354
-38%
|
153
-57%
|
149
-3%
|
222
+49%
|
244
+10%
|
227
-7%
|
236
+4%
|
0
N/A
|
7
N/A
|
7
N/A
|
39
+425%
|
38
-2%
|
19
-51%
|
24
+29%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||
| Cost of Revenue |
(1 868)
|
(1 474)
|
(467)
|
(502)
|
(465)
|
(373)
|
(473)
|
(436)
|
(396)
|
(421)
|
(106)
|
39
|
(121)
|
(106)
|
(150)
|
(111)
|
(63)
|
(63)
|
(87)
|
(94)
|
(81)
|
(87)
|
(82)
|
(66)
|
0
|
(26)
|
(33)
|
(9)
|
(15)
|
|
| Gross Profit |
891
N/A
|
825
-7%
|
272
-67%
|
239
-12%
|
289
+21%
|
263
-9%
|
391
+49%
|
402
+3%
|
452
+12%
|
432
-4%
|
254
-41%
|
327
+29%
|
484
+48%
|
496
+2%
|
422
-15%
|
242
-43%
|
90
-63%
|
86
-5%
|
135
+57%
|
150
+11%
|
145
-3%
|
149
+2%
|
125
-16%
|
103
-18%
|
0
N/A
|
6
N/A
|
5
-8%
|
10
+82%
|
10
+0%
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(546)
|
(578)
|
(707)
|
(718)
|
(464)
|
(309)
|
(313)
|
(297)
|
(319)
|
(302)
|
(190)
|
(179)
|
(220)
|
(244)
|
(821)
|
(575)
|
(198)
|
(340)
|
(277)
|
(286)
|
(242)
|
(228)
|
62
|
37
|
(61)
|
(56)
|
(25)
|
(35)
|
(22)
|
|
| Selling, General & Administrative |
(582)
|
(609)
|
(709)
|
(722)
|
(467)
|
(334)
|
(317)
|
(279)
|
(346)
|
(333)
|
(192)
|
(187)
|
(251)
|
(257)
|
(520)
|
(497)
|
(169)
|
(173)
|
(275)
|
(281)
|
(238)
|
(224)
|
(25)
|
(37)
|
(62)
|
(71)
|
(18)
|
(22)
|
(22)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(1)
|
0
|
(1)
|
0
|
0
|
|
| Other Operating Expenses |
36
|
31
|
2
|
4
|
3
|
25
|
4
|
(18)
|
27
|
30
|
2
|
8
|
31
|
12
|
(301)
|
(78)
|
(28)
|
(167)
|
(1)
|
(4)
|
(4)
|
(4)
|
89
|
73
|
2
|
15
|
(6)
|
(13)
|
0
|
|
| Operating Income |
344
N/A
|
247
-28%
|
(435)
N/A
|
(478)
-10%
|
(175)
+63%
|
(46)
+74%
|
78
N/A
|
105
+33%
|
132
+27%
|
130
-2%
|
64
-51%
|
148
+131%
|
264
+79%
|
252
-5%
|
(399)
N/A
|
(333)
+17%
|
(107)
+68%
|
(255)
-137%
|
(142)
+44%
|
(136)
+4%
|
(96)
+29%
|
(79)
+17%
|
(20)
+75%
|
(22)
-14%
|
(54)
-140%
|
(43)
+21%
|
(19)
+55%
|
(25)
-31%
|
(12)
+51%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
(29)
|
(40)
|
(57)
|
(55)
|
(51)
|
(60)
|
(60)
|
(52)
|
(29)
|
(11)
|
(23)
|
(54)
|
(37)
|
(21)
|
(85)
|
(390)
|
(100)
|
(104)
|
(66)
|
(74)
|
(67)
|
(62)
|
(30)
|
(32)
|
8
|
10
|
(27)
|
(46)
|
(14)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(678)
|
(1 023)
|
(423)
|
(78)
|
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(78)
|
0
|
(147)
|
0
|
9
|
54
|
14
|
(31)
|
0
|
0
|
12
|
0
|
(7)
|
0
|
(0)
|
|
| Total Other Income |
(8)
|
(0)
|
(8)
|
(0)
|
(5)
|
(5)
|
(1)
|
0
|
(1)
|
(0)
|
(4)
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
308
N/A
|
205
-33%
|
(1 177)
N/A
|
(1 556)
-32%
|
(653)
+58%
|
(188)
+71%
|
17
N/A
|
52
+202%
|
101
+92%
|
117
+16%
|
36
-69%
|
93
+161%
|
226
+144%
|
231
+2%
|
(562)
N/A
|
(723)
-29%
|
(355)
+51%
|
(359)
-1%
|
(200)
+44%
|
(155)
+22%
|
(149)
+4%
|
(172)
-16%
|
(50)
+71%
|
(55)
-10%
|
(33)
+39%
|
(33)
+2%
|
(53)
-64%
|
(71)
-33%
|
(26)
+63%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Tax Provision |
(73)
|
(43)
|
68
|
76
|
(21)
|
(51)
|
(15)
|
(16)
|
(13)
|
(15)
|
(11)
|
(16)
|
(16)
|
(17)
|
(40)
|
(30)
|
(0)
|
(0)
|
9
|
9
|
(3)
|
(4)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
234
|
162
|
(1 109)
|
(1 480)
|
(674)
|
(239)
|
2
|
36
|
88
|
101
|
25
|
77
|
211
|
214
|
(602)
|
(752)
|
(355)
|
(359)
|
(191)
|
(146)
|
(151)
|
(176)
|
(50)
|
(55)
|
(33)
|
(33)
|
(53)
|
(71)
|
(26)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
6
|
9
|
6
|
6
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
234
N/A
|
162
-31%
|
(1 109)
N/A
|
(1 480)
-33%
|
(674)
+54%
|
(239)
+64%
|
2
N/A
|
36
+1 639%
|
88
+142%
|
101
+16%
|
116
+15%
|
147
+26%
|
165
+13%
|
167
+1%
|
(958)
N/A
|
(1 036)
-8%
|
(588)
+43%
|
(676)
-15%
|
(358)
+47%
|
(277)
+23%
|
(150)
+46%
|
(175)
-17%
|
(66)
+62%
|
(72)
-8%
|
(144)
-99%
|
(143)
+0%
|
(53)
+63%
|
(71)
-33%
|
(26)
+63%
|
|
| EPS (Diluted) |
0.23
N/A
|
0.15
-35%
|
-1.03
N/A
|
-1.37
-33%
|
-0.62
+55%
|
-0.22
+65%
|
0
N/A
|
0.03
N/A
|
0.06
+100%
|
0.06
N/A
|
0.07
+17%
|
0.09
+29%
|
0.09
N/A
|
0.09
N/A
|
-0.61
N/A
|
-0.62
-2%
|
-0.33
+47%
|
-0.35
-6%
|
-0.18
+49%
|
-0.14
+22%
|
-0.79
-464%
|
-0.09
+89%
|
-0.34
-278%
|
-0.28
+18%
|
-0.72
-157%
|
-0.64
+11%
|
-0.2
+69%
|
-0.12
+40%
|
-0.04
+67%
|
|
Switch to:
Switch to:
See Also
Discover More
